Literature DB >> 25008043

Microglia and inflammation: conspiracy, controversy or control?

Adelaide Fernandes1, Leonor Miller-Fleming, Teresa F Pais.   

Abstract

Microglial cells contribute to normal function of the central nervous system (CNS). Besides playing a role in the innate immunity, they are also involved in neuronal plasticity and homeostasis of the CNS. While microglial cells get activated and undergo phenotypic changes in different disease contexts, they are far from being the "villains" in the CNS. Mounting evidence indicates that microglial dysfunction can exacerbate the pathogenesis of several diseases in the CNS. Several molecular mechanisms tightly regulate the production of inflammatory and toxic factors released by microglia. These mechanisms involve the interaction with other glial cells and neurons and the fine regulation of signaling and transcription activation pathways. The purpose of this review is to discuss microglia activation and to highlight the molecular pathways that can counteract the detrimental role of microglia in several neurologic diseases. Recent work presented in this review support that the understanding of microglial responses can pave the way to design new therapies for inflammatory diseases of the CNS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25008043     DOI: 10.1007/s00018-014-1670-8

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  187 in total

1.  Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

Authors:  Ana Griciuc; Alberto Serrano-Pozo; Antonio R Parrado; Andrea N Lesinski; Caroline N Asselin; Kristina Mullin; Basavaraj Hooli; Se Hoon Choi; Bradley T Hyman; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-04-25       Impact factor: 17.173

2.  Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons.

Authors:  S Lin; Y Zhang; R Dodel; M R Farlow; S M Paul; Y Du
Journal:  Neurosci Lett       Date:  2001-11-23       Impact factor: 3.046

3.  Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+ T cell proliferation.

Authors:  Teresa F Pais; Sukalyan Chatterjee
Journal:  J Neuroimmunol       Date:  2005-04-12       Impact factor: 3.478

4.  Engineered stem cell-derived microglia as therapeutic vehicle for experimental autoimmune encephalomyelitis.

Authors:  C Beutner; V Lepperhof; A Dann; B Linnartz-Gerlach; S Litwak; I Napoli; M Prinz; H Neumann
Journal:  Gene Ther       Date:  2013-01-17       Impact factor: 5.250

5.  Pilot study of minocycline in relapsing-remitting multiple sclerosis.

Authors:  Yunyan Zhang; Luanne M Metz; V Wee Yong; Robert B Bell; Michael Yeung; David G Patry; J Ross Mitchell
Journal:  Can J Neurol Sci       Date:  2008-05       Impact factor: 2.104

6.  Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta production.

Authors:  Cinzia Dello Russo; Anne I Boullerne; Vitaliy Gavrilyuk; Douglas L Feinstein
Journal:  J Neuroinflammation       Date:  2004-06-30       Impact factor: 8.322

7.  Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.

Authors:  Wenjun Zhu; Crystal Acosta; Brian MacNeil; Claudia Cortes; Howard Intrater; Yuewen Gong; Mike Namaka
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

8.  Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status.

Authors:  Daphne Y S Vogel; Elly J F Vereyken; Judith E Glim; Priscilla D A M Heijnen; Martina Moeton; Paul van der Valk; Sandra Amor; Charlotte E Teunissen; Jack van Horssen; Christine D Dijkstra
Journal:  J Neuroinflammation       Date:  2013-03-04       Impact factor: 8.322

9.  Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies.

Authors:  Gaia Codolo; Nicoletta Plotegher; Tommaso Pozzobon; Marco Brucale; Isabella Tessari; Luigi Bubacco; Marina de Bernard
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 10.  TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease.

Authors:  Melissa K McCoy; Malú G Tansey
Journal:  J Neuroinflammation       Date:  2008-10-17       Impact factor: 8.322

View more
  38 in total

1.  SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice.

Authors:  Ban Wang; Youjun Zhang; Wei Cao; Xunbing Wei; James Chen; Weihai Ying
Journal:  Neurochem Res       Date:  2016-06-27       Impact factor: 3.996

2.  Social interaction modulates the neuroinflammatory response to global cerebral ischemia in male mice.

Authors:  Monica M Gaudier-Diaz; Ning Zhang; Adam H Haines; Min Zhou; A Courtney DeVries
Journal:  Brain Res       Date:  2017-08-12       Impact factor: 3.252

Review 3.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

4.  (7R,8S)-Dehydrodiconiferyl Alcohol Suppresses Lipopolysaccharide-Induced Inflammatory Responses in BV2 Microglia by Inhibiting MAPK Signaling.

Authors:  Si-Yu Liu; Peng Xu; Xiao-Ling Luo; Jin-Feng Hu; Xin-Hua Liu
Journal:  Neurochem Res       Date:  2016-03-09       Impact factor: 3.996

Review 5.  Pathogenic mechanisms following ischemic stroke.

Authors:  Seyed Esmaeil Khoshnam; William Winlow; Maryam Farzaneh; Yaghoob Farbood; Hadi Fathi Moghaddam
Journal:  Neurol Sci       Date:  2017-04-17       Impact factor: 3.307

Review 6.  Stem Cell Therapy for Spinal Cord Injury: A Review of Recent Clinical Trials.

Authors:  Emmanouil I Damianakis; Ioannis S Benetos; Dimitrios Stergios Evangelopoulos; Aikaterini Kotroni; John Vlamis; Spyridon G Pneumaticos
Journal:  Cureus       Date:  2022-04-28

Review 7.  Current disease modifying approaches to treat Parkinson's disease.

Authors:  Dan Lindholm; Johanna Mäkelä; Valentina Di Liberto; Giuseppa Mudò; Natale Belluardo; Ove Eriksson; Mart Saarma
Journal:  Cell Mol Life Sci       Date:  2015-11-30       Impact factor: 9.261

8.  Melatonin Ameliorates Lipopolysaccharide-Induced Microglial Inflammation via Triggering SIRT1/HMGB1 Signaling Axis.

Authors:  Enkhmurun Chibaatar; Kai Le; Idriss Ali Abdoulaye; Shanshan Wu; Yijing Guo
Journal:  J Mol Neurosci       Date:  2020-09-10       Impact factor: 3.444

9.  The role of N-glycan modification of TNFR1 in inflammatory microglia activation.

Authors:  Lijian Han; Dongmei Zhang; Tao Tao; Xiaolei Sun; Xiaojuan Liu; Guizhou Zhu; Zhiwei Xu; Liang Zhu; Yu Zhang; Wangrui Liu; Kaifu Ke; Aiguo Shen
Journal:  Glycoconj J       Date:  2015-10-09       Impact factor: 2.916

Review 10.  Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Authors:  Tobias Engel; Jonathon Smith; Mariana Alves
Journal:  J Inflamm Res       Date:  2021-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.